About Galaxy Therapeutics
Galaxy Therapeutics is a private company based in Milpitas, California, incorporated in 2020 in Delaware. It has reported $13,048,500 raised in four offerings on Form D since July 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 2022 | Jul 31, 2024 | $7,579,500target not set | 50 | $151K | Options, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Jun 2, 2021 | Jul 31, 2024 | $2,139,000target not set | 26 | $82,269 | Options, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Feb 12, 2020 | Jul 31, 2024 | $3,005,000target not set | 47 | $63,936 | Options, Simple Agreement for future equity.Rule 506(b) | Form D ↗ |
| Feb 12, 2020 | Feb 14, 2020 | $325,000target not set | 3 | $108K | Options, SIMPLE AGREEMENT FOR FUTURE EQUITYRule 506(b) | Form D ↗ |
| Total, four offerings | $13,048,500 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Galaxy Therapeutics's Form D filed Jul 31, 2024.
OZ
Osama Zaidat
Executive officer and director
Earlier filings also listed Thomas Wolfe (executive officer and director, last listed Feb 2020), Edgard Pereira (executive officer and director, last listed Feb 2020) and Aamir Badruddin (executive officer and director, last listed Feb 2020).